Comparing Botox and surgery for stomach drainage during esophagectomy
Official title: Comparative Effectiveness of Intrapyloric Botulinum Toxin Injection Versus Pyloromyotomy for Pyloric Drainage During Esophagectomy: A Registry-Based, Pragmatic Randomized Noninferiority Trial
Run by The Cleveland Clinic · NCT06721520 · Data updated 2026-11-12
This study is testing whether Botox injections can help people who have had esophagus surgery manage delayed stomach emptying just as well as surgery can.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 170 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | December 3, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | May 31, 2028 |
| Registry record updated | February 25, 2026 |
| Trial ID | NCT06721520 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who are scheduled for elective esophagectomy and can receive either treatment method.
✕Probably not a fit
Patients undergoing emergency esophagectomy or those with contraindications to Botox, such as certain neuromuscular diseases, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of botulinum toxin (Botox) versus pyloromyotomy for pyloric drainage in patients undergoing elective esophagectomy. It is a pragmatic, registry-based, randomized clinical trial that will compare outcomes related to delayed gastric emptying after surgery. Participants will be randomly assigned to receive either intrapyloric Botox injection or pyloromyotomy, with the goal of determining if Botox is as effective as the surgical method in alleviating symptoms of delayed gastric emptying at six months postoperatively.
Why it matters
Potential benefit: If successful, this study could provide a less invasive alternative to surgery for managing delayed gastric emptying in patients undergoing esophagectomy.
How similar studies have gone: While the use of Botox for gastric drainage is explored in other contexts, this specific comparison with pyloromyotomy is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older * Undergoing elective esophagectomy (thoracoabdominal, Ivor-Lewis, McKeown) * Receiving a gastric conduit for alimentary reconstruction * Technically able to receive either intrapyloric Botox injection or pyloromyotomy as ultimately determined intraoperatively * Willing and able to provide informed consent * Willing and able to participate in long-term follow up including study visits and surveys Exclusion Criteria: * Undergoing emergent esophagectomy (e.g., for esophageal perforation) * Patients with underlying neuromuscular disease as Botox would be contraindicated (amyotrophic lateral sclerosis, myasthenia gravis, muscular dystrophies, Lambert-Eaton syndrome) * Patients undergoing left thoracoabdominal without left cervical neck incision (i.e., Sweet esophagectomy) - excluded due to the extent of gastric resection * Pregnancy * Allergy or hypersensitivity to botulinum toxin * Cannot feasibly receive both pyloric interventions as determined intraoperatively (e.g., patients with central obesity undergoing thoracoabdominal esophagectomy makes for a technically difficult pyloromyotomy)
Where it's running
-
Cleveland Clinic
Cleveland, Ohio, United States Recruiting
Study contacts
- Principal investigator: Siva Raja, MD — The Cleveland Clinic
- Study coordinator: Andrew Conner, MD
- Email: connera5@ccf.org
- Phone: 216-316-6644
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry for identifying risk factors of esophageal cancer
This study is trying to find out if certain blood and tissue markers can help identify people at risk for esophageal cancer by looking at their medical history and samples.
-
Pain management plan implementation for major open abdominal surgeries
This trial tests an opioid-epidural pain management approach to see if it improves post-surgical pain control for adults undergoing open abdominal procedures like colectomy, hepatectomy, and nephrectomy.
-
POEM vs Heller myotomy with Dor fundoplication for achalasia
This trial tests POEM against laparoscopic Heller myotomy with Dor fundoplication to see which procedure better helps adults with achalasia.
-
See if Continuous Glucose Monitoring can help diagnose dumping syndrome after esophagectomy
Researchers are testing whether a wearable continuous glucose monitor can help spot dumping syndrome in people who had esophageal cancer surgery with a stomach tube reconstruction.
-
Multicenter chest X-ray screening for thoracic diseases
This project will test whether routine chest X-rays can detect thoracic problems in adults who come for routine health examinations.
-
A registry for adults with esophageal movement and reflux problems.
This project will collect esophageal function tests (manometry, pH-impedance, FLIP) and clinical data from adults with reflux or swallowing symptoms to see if combining these results helps guide diagnosis and long-term care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.